AUPH
Aurinia Pharmaceuticals (AUPH) Earnings
Review Aurinia Pharmaceuticals (AUPH) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- 2.07
- Trailing EPS
- 2.29
- Annual revenue
- $283.06M
- Trailing revenue
- $311.51M
- Next earnings date
- 2026-08-06
- Earnings data source
- MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis + Finnhub earnings
Aurinia Pharmaceuticals (AUPH) Earnings research
The AUPH earnings page organizes the available earnings-per-share and revenue context for Aurinia Pharmaceuticals. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.